Use of rotigotine for treating and preventing Parkinson's plus syndrome

Details for Australian Patent Application No. 2005226911 (hide)

Owner UCB Pharma GmbH

Inventors Scheller, Dieter

Agent Davies Collison Cave

Pub. Number AU-B-2005226911

PCT Pub. Number WO2005/092331

Priority 10 2004 014 841.4 24.03.04 DE

Filing date 22 March 2005

Wipo publication date 6 October 2005

Acceptance publication date 10 February 2011

International Classifications

A61K 31/381 (2006.01) - having five-membered rings

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/092331 Priority application(s): WO2005/092331

25 November 2010 Alteration of Name

  The name of the applicant has been altered to UCB Pharma GmbH

10 February 2011 Application Accepted

  Published as AU-B-2005226911

9 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005226914-Novel pharmaceutical compositions comprising agonists of the thyroid receptor

2005226910-Oral matrix formulations comprising licarbazepine